Douglas A. Lauffenburger

Douglas A. Lauffenburger is the Ford Professor of Engineering at the Massachusetts Institute of Technology (MIT), holding a joint appointment in the Department of Biological Engineering and the Department of Mechanical Engineering. He leads the DAL Lab and has served as the founding head of MIT's Biological Engineering Department from 1998 to 2019.

Education:

• B.S. in Chemical Engineering from the University of Illinois
• Ph.D. in Chemical Engineering from the University of Minnesota

Research: Lauffenburger's work integrates experimental and computational approaches to study molecular and cellular networks, with a focus on receptor-mediated cell behavior in health and disease. Key areas include cancer biology, immunotherapy, vaccine development, and microbiome engineering. His lab develops predictive models to bridge molecular mechanisms and cellular functions, emphasizing translational systems biology.

Publications and Grants: Over 591 publications, with recent work addressing SARS-CoV-2 immunity, RSV antibody functions, and tumor immunotherapy. His research spans virology, cancer, and microbiome-driven pathologies. Grants and collaborations with academia and industry drive multi-disciplinary projects.

Teaching: Courses include 20.005 (Bioengineering Fundamentals), 20.260 (Systems Biology), 20.375 (Molecular Cell Bioengineering), and advanced topics in biological engineering.

Awards: While explicit awards are not listed, his leadership roles and contributions to founding MIT's Biological Engineering program reflect significant recognition in the field.

Labs/Teams: The DAL Lab collaborates globally, focusing on quantitative systems biology and translational research. Key projects include immunotherapy design, vaccine efficacy studies, and microbiome-host interactions.